Liver Cancer

Bayer’s Nexavar Wins FDA Approval for Liver Cancer Treatment
Category: Cancer, Liver Cancer |

The FDA has approved Bayer HealthCare AG’s drug, Nexavar (sorafenib) in patients with hepatocellular carcinoma when the cancer can not be removed surgically. Hepatocellular carcinoma is a type of liver cancer.

FULL STORY »

20th November 2007 | 0 Comments

up to content »

rss posts

Latest Posts
ACCORD Clinical Trial: Strategy Targeting Blood Sugar to Near-Normal Levels Increases Mortality in Diabetics at High Risk for Heart Disease
Complementary and Alternative Medicine Education Materials Available from U.S. Government Agency
Breastfeeding Can Prevent Infant Death and HIV Infection in Poor Countries
Repeated Exposure to Pesticides May Increase Diabetes Risk
Genetic variation in Mitochondria DNA Contributes to Age-related Macular Degeneration (AMD)
Awareness of Heart Attack Symptoms Lower Among Blacks and Hispanics
Nerve Cells Compete for Survival
Heart Attack Symptoms Less Likely to be Recognized in Women
FDA Approves Sucampo Pharmaceuticals’ Amitiza for Treatment of Irritable Bowel Syndrome
Aspirin Resistant Patients More Likely to Suffer Heart Attack or Stroke

Account
Login

Current Location : Home » category » Liver Cancer

Bayer’s Nexavar Wins FDA Approval for Liver Cancer Treatment Category: Cancer, Liver Cancer |

Categories

Latest Posts

Account

Bayer’s Nexavar Wins FDA Approval for Liver Cancer Treatment
Category: Cancer, Liver Cancer |